SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-008657
Filing Date
2018-11-06
Accepted
2018-11-06 16:57:48
Documents
63
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptgx-20180930x10q.htm 10-Q 2016815
2 EX-31.1 ptgx-20180930ex31137b4f8.htm EX-31.1 12358
3 EX-31.2 ptgx-20180930ex3123af378.htm EX-31.2 13471
4 EX-32.1 ptgx-20180930ex321604c43.htm EX-32.1 13757
  Complete submission text file 0001558370-18-008657.txt   7195223

Data Files

Seq Description Document Type Size
5 EX-101.INS ptgx-20180930.xml EX-101.INS 1654506
6 EX-101.SCH ptgx-20180930.xsd EX-101.SCH 45688
7 EX-101.CAL ptgx-20180930_cal.xml EX-101.CAL 46200
8 EX-101.DEF ptgx-20180930_def.xml EX-101.DEF 141701
9 EX-101.LAB ptgx-20180930_lab.xml EX-101.LAB 372351
10 EX-101.PRE ptgx-20180930_pre.xml EX-101.PRE 312655
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 181163743
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1